news
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed…
14 October 2019 | By Rachael Harper (Drug Target Review)
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed to both detect and destroy RNA-based viruses in human cells.